✦ LIBER ✦

Thienopyridine therapy and risk for cardiovascular events in secondary prevention

✍ Scribed by Peter P. Toth; Annemarie Armani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary and secondary prevention of card

✍ Heidemarie Pilz 📂 Article 📅 2005 🏛 Springer Vienna 🌐 German ⚖ 755 KB

Cardiovascular risks in type 2 diabetes

✍ P Ducimetière 📂 Article 📅 2005 🏛 Masson Editeur 🌐 French ⚖ 64 KB

Optimal Medical Therapy, Lifestyle Inter

✍ Philip Joseph; Koon Teo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 163 KB

Atorvastatin Efficacy in the Primary and

✍ Prof. Marcello Arca, Achille Gaspardone 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 156 KB

Therapy for Triggered Acute Risk Prevent

✍ Tofler, Geoffrey H.; Spinaze, Monica; Shaw, Elizabeth; Buckley, Thomas 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Role of ASA in the primary and secondary

✍ Rubén Casado-Arroyo; Fatih Bayrak; Andrea Sarkozy; Gian-Battista Chierchia; Carl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB